immunologic sensitization
Recently Published Documents


TOTAL DOCUMENTS

15
(FIVE YEARS 0)

H-INDEX

10
(FIVE YEARS 0)

2019 ◽  
Vol 38 (3) ◽  
pp. 285-294 ◽  
Author(s):  
Natasha Aleksova ◽  
Ana C Alba ◽  
Chun-Po S. Fan ◽  
Brigitte Mueller ◽  
Lisa M Mielniczuk ◽  
...  

2008 ◽  
Vol 135 (6) ◽  
pp. 1372-1379.e1 ◽  
Author(s):  
Isaac George ◽  
Patrick Colley ◽  
Mark J. Russo ◽  
Timothy P. Martens ◽  
Elizabeth Burke ◽  
...  

2006 ◽  
Vol 291 (5) ◽  
pp. L880-L886 ◽  
Author(s):  
Anthony M. Szema ◽  
Sayyed A. Hamidi ◽  
Sergey Lyubsky ◽  
Kathleen G. Dickman ◽  
Suni Mathew ◽  
...  

The mechanisms leading to asthma, and those guarding against it, are yet to be fully defined. The neuropeptide VIP is a cotransmitter, together with nitric oxide (NO), of airway relaxation, and a modulator of immune and inflammatory responses. NO-storing molecules in the lung were recently shown to modulate airway reactivity and were proposed to have a protective role against the disease. We report here that mice with targeted deletion of the VIP gene spontaneously exhibit airway hyperresponsiveness to the cholinergic agonist methacholine as well as peribronchiolar and perivascular cellular infiltrates and increased levels of inflammatory cytokines in bronchoalveolar lavage fluid. Immunologic sensitization and challenge with ovalbumin generally enhanced the airway hyperresponsiveness and airway inflammation in all mice. Intraperitoneal administration of VIP over a 2-wk period in knockout mice virtually eliminated the airway hyperresponsiveness and reduced the airway inflammation in previously sensitized and challenged mice. The findings suggest that 1) VIP may be an important component of endogenous anti-asthma mechanisms, 2) deficiency of the VIP gene may predispose to asthma pathogenesis, and 3) treatment with VIP or a suitable agonist may offer potentially effective replacement therapy for this disease.


ASAIO Journal ◽  
2006 ◽  
Vol 52 (2) ◽  
pp. 53A
Author(s):  
Michael Al-Deiri ◽  
Dilek Guersoy ◽  
Latif Arusoglu ◽  
Wolfgang Prohaska ◽  
Wihlem Koester Eiserfunke ◽  
...  

2003 ◽  
Vol 125 (3) ◽  
pp. 578-591 ◽  
Author(s):  
Ranjit John ◽  
Katherine Lietz ◽  
Michael Schuster ◽  
Yoshifumi Naka ◽  
Vivek Rao ◽  
...  

Allergy ◽  
2001 ◽  
Vol 56 (1) ◽  
pp. 2-12 ◽  
Author(s):  
V. P. Kurup ◽  
J. N. Fink

1996 ◽  
Vol 271 (1) ◽  
pp. G147-G155 ◽  
Author(s):  
P. B. Bijlsma ◽  
A. J. Kiliaan ◽  
G. Scholten ◽  
M. Heyman ◽  
J. A. Groot ◽  
...  

The effects of the secretagogues forskolin and carbachol on protein uptake in isolated ileum of rats were studied. The mucosal-to-serosal transport of horseradish peroxidase (HRP, mol mass 40 kDa) was measured in Ussing chambers, and afterwards tissues were processed for electron microscopy. In the absence of secretagogues, the flux of enzymatically active HRP was 5 pmol.cm-2.h-1 at a mucosal concentration of 10 microM. Electron micrographs showed vesicles filled with active HRP in enterocytes but no HRP activity in intercellular spaces. Forskolin decreased HRP activity in the cells. Carbachol increased the amount of HRP-filled vesicles in enterocytes and induced HRP filling in some intercellular spaces and tight junctions in the upper parts of the villi. The transepithelial flux of intact HRP increased more than 2.5-fold. This effect was suppressed by atropine. We conclude that cholinergic activation can increase the uptake of intact protein via endocytosis and the transepithelial passage by the induction of a diffusional paracellular pathway. We speculate that the increased transport of intact protein through the intestinal barrier may influence immunologic sensitization to food allergens.


1993 ◽  
Vol 91 (5) ◽  
pp. 979-986 ◽  
Author(s):  
A DESJARDINS ◽  
C BENOIT ◽  
H GHEZZO ◽  
J LARCHEVDQUE ◽  
C LEBLANC ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document